Codexis Inc (CDXS)
Healthcare
Biotechnology
1.40 $
-5.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Codexis Inc (CDXS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 80.8% of the shares are freely tradable; institutional investors hold 74.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
74.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
7.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
80.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
3.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
91Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Aberdeen Group PLC | 9.55 | 8,680,368 | +9.0 | 03/31/2026 |
| BlackRock Inc | 7.73 | 7,028,773 | -5.0 | 03/31/2026 |
| Opaleye Management Inc | 7.46 | 6,785,000 | -0.1 | 03/31/2026 |
| Vanguard Group Inc | 5.44 | 4,941,542 | +5.8 | 12/31/2025 |
| Nantahala Capital Management, LLC | 4.54 | 4,123,613 | +3.3 | 03/31/2026 |
| Millennium Management LLC | 4.40 | 3,998,130 | +27.5 | 03/31/2026 |
| Telemark Asset Management, LLC | 4.23 | 3,846,411 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.04 | 3,668,507 | +0.0 | 03/31/2026 |
| Ameriprise Financial Inc | 3.74 | 3,400,496 | -10.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| abrdn Healthcare Investors | 5.46 | 4,958,743 | -5.8 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.